- Integrated Gene-to-Market Pipeline
One contract from DNA design through GMP release eliminates data gaps and keeps accountability singular. - Modular Bioreactor Suite
Bench-scale to ≥20 000 L in both stainless and single-use formats, accommodating fed-batch, perfusion, and continuous runs without a facility transfer. - Robust Strain & Cell-Line Engineering
CRISPR/Cas toolkits, high-throughput screening, and genomic-stability analytics that compress early development timelines. - Scalable Downstream Toolbox
Depth filtration, multicolumn chromatography, TFF, spray- and freeze-dry, with process-analytical sensors for every step. - End-to-End Quality Systems
ISO 9001, 13485, and cGMP alignment; digital LIMS; real-time deviation alerts—because right-first-time is cheaper than re-work. - Regulatory Fluency
In-house writers who have filed GRAS, IND, IMPD, and Novel-Food dossiers—steering projects through FDA, EMA, and Singapore SFA alike. - Transparent Cost Modeling
Live dashboards showing raw-material, labor, energy, and depreciation inputs so sponsors can forecast COGS before scale-up dollars are spent. - Data Security & IP Firewalls
SOC-2 compliant cloud, segregated lab space, and client-embedded scientists—trust is more than an NDA. - Sustainability Metrics
ISO 14064 life-cycle accounting, renewable-energy PPAs, and water-recovery loops that future-proof both compliance and brand storytelling. - Culture of Collaboration
Weekly joint tech reviews, shared digital twins, and swift change-control—because speed and partnership, not stainless steel, differentiate the great from the merely equipped.
If your prospective CDMO can’t tick every box, you’re outsourcing risk, not just manufacturing.
Want to learn about Viral Vectors? Check out this blog —>Scaling Viral Vector Production for Gene Therapy: From Bench to GMP Manufacturing.